Ģ����ý

������ܾ��������, the largest independent kidney dialysis lab in the U.S.

Launched the  to assist nephrologists and professional dialysis staff in improving clinical outcomes and standards of practice.

Acquired dialysis provider Renal Care Group, a specialized dialysis services company that provided care to patients with kidney disease.

Fresenius Renal Pharmaceuticals launched an authorized generic equivalent of PhosLo in partnership with Sandoz Pharmaceutical company.

�����ܲԳ������� , enabling patients to order and receive medications and supplies directly from specially trained renal pharmacists.

 Holdings to enhance access to high-quality outpatient vascular care.

Fresenius Renal Pharmaceuticals launched Velphoro®, a phosphate binder used in the treatment of hyperphosphatemia in patients who receive dialysis.

Renal Therapies Group introduced the , part of the Crit-Line® technology product line. The CLiC device non-invasively measures hematocrit, oxygen saturation, and percent change in intravascular blood volume during a patientĢ����ý�s hemodialysis treatment.

 to provide value based care services to Humana members living with end stage renal disease.

During a record-setting , our Disaster Response Team mobilized ahead of hurricanes Irma, Harvey, and Maria, ensuring our dialysis patients received the life-sustaining care they needed and our employees were safe and supported.

Ģ����ý and Humacyte, Inc. Ģ����ý� a medical research, discovery, and development company focused on regenerative medicine Ģ����ý� announced a .

Broke ground on a new  in Knoxville, TN, supporting efforts to increase the supplies and timing for the growing number of patients who choose home dialysis.